MRK and ABBV Related Headlines
Go Back- U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
- U.S. House committee opens investigation into Merck, AbbVie China drug trials - Reuters
- Trump to unveil more discounted prescription drug options - CNBC
- Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
- Bernstein on US Pharma and Biotech: Who might buy whom?
- RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
- Barclays launches U.S. biopharma coverage with four preferred picks
- This U.S. biotech stock is Bernstein's Top Pick for 2026
- Revolution Medicines stock rises on Merck acquisition talks
- Merck (MRK) in Talks to buy Revolution Medicines (RVMD) - FT
- Merck upgraded on post-Keytruda growth, AbbVie cut as upside baked in - Wolfe
- Trump to announce prescription drug price agreements
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
